Literature DB >> 7059470

Cells bearing Fc receptors in human malignant solid tumours.

J L Svennevig, T R Andersson.   

Abstract

Fc-receptor-bearing cells forming EA rosettes with antibody-coated human erythrocytes (Ripley) were studied in cell suspensions and in purified preparations of mononuclear cells (MC) from 20 human malignant tumours. The EA rosettes were studied in preparations made by cytocentrifugation and the rosette-forming cells identified by their nonspecific-esterase activity and phagocytic capacity. Fc receptors were found on 16 +/- 20% of all cells in the primary cell suspensions. Significantly more tumour-infiltrating lymphocytes had detectable Fc receptors normal control subjects (14 +/- 6%). There was a significant correlation between the proportion of lymphocytes lacking T and B markers (null cells) and the proportion of lymphocytes with Fc receptors. Fc receptors were also found on most tumour-infiltrating macrophages, on some T lymphocytes and polymorphonuclear cells and on a smaller percentage of the tumour cells. The significance of the Fc receptor and its usefulness as a marker of "host infiltration" into the tumours is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059470      PMCID: PMC2010895          DOI: 10.1038/bjc.1982.34

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  ADCC effector cells in a murine adenocarcinoma. I. Evidence for blood-borne bone-marrow-derived monocytes.

Authors:  J S Haskill
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

2.  Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers.

Authors:  G W Wood; K A Gollahon
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

Review 3.  Identification of three different human lymphocyte populations by surface markers.

Authors:  S S Froland; J B Natvig
Journal:  Transplant Rev       Date:  1973

4.  Receptors for immunoglobulin Fc in human malignant tissues.

Authors:  O Tonder; S Thunold
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487

5.  Similarities of Fc receptors in human malignant tissue and normal lymphoid tissue.

Authors:  O Tonder; P A Morse; L J Humphrey
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Identification of resting human T and B lymphocytes by acid alpha-naphthyl acetate esterase staining combined with rosette formation with Staphylococcus aureus strain Cowan 1.

Authors:  A Ranki; T H Tötterman; P Häyry
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Characterization of the mononuclear cell infiltrate in human malignant melanoma.

Authors:  R Roubin; J P Césarini; W H Fridman; J Pavie-Fischer; H H Peter
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

8.  Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

Authors:  B M Vose; F Vánky; E Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

9.  Fc receptor-bearing cells as a reliable marker for quantitation of host lymphoreticular infiltration of progressively growing solid tumors.

Authors:  R S Kerbel; H F Pross
Journal:  Int J Cancer       Date:  1976-10-15       Impact factor: 7.396

Review 10.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

View more
  5 in total

Review 1.  Fc receptor--more answers, more questions.

Authors:  L Fornůsek; V Vĕtvicka
Journal:  Folia Microbiol (Praha)       Date:  1984       Impact factor: 2.099

Review 2.  Fc gamma receptors and cancer.

Authors:  Lydie Cassard; Joël Cohen-Solal; Sophie Camilleri-Broët; Emilie Fournier; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  Springer Semin Immunopathol       Date:  2006-11-10

Review 3.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

4.  Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.

Authors:  Joel F G Cohen-Solal; Lydie Cassard; Emilie M Fournier; Shannon M Loncar; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  Dermatol Res Pract       Date:  2010-06-28

5.  Characterisation of macrophages infiltrating human mammary carcinomas.

Authors:  R J Steele; M Brown; O Eremin
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.